Stocktoria
Guardian Pharmacy Services, Inc. GRDN
NYSE · XNYS · stock · Retail-Drug Stores and Proprietary Stores · website · IPO 2024-09-26
Chart by TradingView
6/9
Piotroski F — financial health
3.85
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 |
|---|---|---|
| Financials | ||
| Revenue | $1.4B | $1.2B |
| Gross profit | $292.7M | $244.4M |
| Operating income | $72.7M | -$62.9M |
| Net income | $49.2M | -$110.0M |
| Operating cash flow | $100.3M | $58.0M |
| Total assets | $412.7M | $320.8M |
| Total liabilities | $194.7M | $170.8M |
| Shareholders' equity | $217.9M | $150.0M |
| Ratios | ||
| Gross margin | 20.2% | 19.9% |
| Operating margin | 5.0% | -5.1% |
| Net margin | 3.4% | -9.0% |
| Return on assets | 11.9% | -34.3% |
| Return on equity | 22.6% | -73.4% |
| Debt / equity | 0.00× | 0.00× |
| Current ratio | 1.38 | 1.05 |
| Revenue growth | 17.9% | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 99,989 | $3.8M |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 3.85 (safe)
- Working capital / assets 0.148
- Retained earnings / assets 0.161
- EBIT / assets 0.176
- Equity / liabilities 1.119
Sector peers
WMT · CVS · COST · JD · HD · KR · all Retail Trade →
Source: SEC EDGAR filings · CIK 0001802255 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.